Cargando…

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials

BACKGROUND: Primaquine (PQ) actively clears mature Plasmodium falciparum gametocytes but in glucose-6-phosphate dehydrogenase deficient (G6PDd) individuals can cause hemolysis. We assessed the safety of low-dose PQ in combination with artemether-lumefantrine (AL) or dihydroartemisinin-piperaquine (D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bastiaens, Guido J. H., Tiono, Alfred B., Okebe, Joseph, Pett, Helmi E., Coulibaly, Sam A., Gonçalves, Bronner P., Affara, Muna, Ouédraogo, Alphonse, Bougouma, Edith C., Sanou, Guillaume S., Nébié, Issa, Bradley, John, Lanke, Kjerstin H. W., Niemi, Mikko, Sirima, Sodiomon B., d’Alessandro, Umberto, Bousema, Teun, Drakeley, Chris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764271/ https://www.ncbi.nlm.nih.gov/pubmed/29324864 http://dx.doi.org/10.1371/journal.pone.0190272

Ejemplares similares

Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
por: Gonçalves, Bronner P., et al.
Publicado: (2016)

G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials
por: Sepúlveda, Nuno, et al.
Publicado: (2021)

Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children
por: Gonçalves, Bronner P., et al.
Publicado: (2017)

CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum
por: Pett, Helmi, et al.
Publicado: (2019)

Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria
por: Grignard, Lynn, et al.
Publicado: (2019)

CYP2D6 intermediate metabolizer status could slow down Plasmodium falciparum gametocyte clearance after single-dose primaquine
por: Pett, Helmi, et al.
Publicado: (2014)

Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa
por: van Beek, Stijn W., et al.
Publicado: (2021)

Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity
por: Pett, Helmi, et al.
Publicado: (2016)

Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens
por: Tiono, Alfred B, et al.
Publicado: (2009)

Transplacental Transmission of Plasmodium falciparum in a Highly Malaria Endemic Area of Burkina Faso
por: Ouédraogo, Alphonse, et al.
Publicado: (2012)

Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected infection among schoolchildren in Burkina Faso
por: Barry, Aissata, et al.
Publicado: (2019)

Transmission of molecularly undetectable circulating parasite clones leads to high infection complexity in mosquitoes post feeding()
por: Grignard, Lynn, et al.
Publicado: (2018)

Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial
por: Tadesse, Fitsum G., et al.
Publicado: (2017)

Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina Faso
por: Soulama, Issiaka, et al.
Publicado: (2015)

Submicroscopic carriage of Plasmodium falciparum and Plasmodium vivax in a low endemic area in Ethiopia where no parasitaemia was detected by microscopy or rapid diagnostic test
por: Tadesse, Fitsum G, et al.
Publicado: (2015)

Higher gametocyte production and mosquito infectivity in chronic compared to incident Plasmodium falciparum infections
por: Barry, Aissata, et al.
Publicado: (2021)

Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
por: Sirima, Sodiomon B., et al.
Publicado: (2009)

Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children
por: Bougouma, Edith Christiane, et al.
Publicado: (2022)

Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children
por: Tiono, Alfred B., et al.
Publicado: (2023)

Correction: Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
por: Sirima, Sodiomon B., et al.
Publicado: (2010)

Glucose-6-Phosphate Dehydrogenase Status and Risk of Hemolysis in Plasmodium falciparum-Infected African Children Receiving Single-Dose Primaquine
por: Eziefula, Alice C., et al.
Publicado: (2014)

The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial
por: Okebe, Joseph, et al.
Publicado: (2015)

Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso
por: Soulama, Issiaka, et al.
Publicado: (2009)

Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity
por: Gonçalves, Bronner P., et al.
Publicado: (2017)

The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial()
por: Okebe, Joseph, et al.
Publicado: (2016)

Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey
por: Yaro, Jean Baptiste, et al.
Publicado: (2021)

Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial
por: Dicko, Alassane, et al.
Publicado: (2018)

Haemoglobin variants and Plasmodium falciparum malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso
por: Bougouma, Edith C, et al.
Publicado: (2012)

Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial
por: Chen, Ingrid, et al.
Publicado: (2018)

Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso
por: Diarra, Amidou, et al.
Publicado: (2012)

Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa
por: Awandu, Shehu S., et al.
Publicado: (2018)

Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso
por: Diarra, Amidou, et al.
Publicado: (2012)

Malariometric Indices in the Context of Seasonal Malaria Chemoprevention in Children Aged 1.5 to 12 Years during the Period of High Malaria Transmission in the Suburban Area of Banfora, Burkina Faso
por: Ouattara, San M., et al.
Publicado: (2023)

Rationale for short course primaquine in Africa to interrupt malaria transmission
por: Eziefula, Alice C, et al.
Publicado: (2012)

Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso
por: Cherif, Mariama K., et al.
Publicado: (2017)

Malaria Morbidity in High and Seasonal Malaria Transmission Area of Burkina Faso
por: Ouédraogo, Alphonse, et al.
Publicado: (2013)

Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda
por: Eziefula, Alice Chijioke, et al.
Publicado: (2013)

Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial
por: Sirima, Sodiomon B., et al.
Publicado: (2021)

Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
por: Stepniewska, Kasia, et al.
Publicado: (2022)

Contribution of the Rapid LAMP-Based Diagnostic Test (RLDT) to the Evaluation of Enterotoxigenic Escherichia coli (ETEC) and Shigella in Childhood Diarrhea in the Peri-Urban Area of Ouagadougou, Burkina Faso
por: Héma, Alimatou, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dlnqd5u4in79un2kpetec8309b